Literature DB >> 18242728

An efficient strategy for gene targeting and phenotypic assessment in the Plasmodium yoelii rodent malaria model.

Sebastian A Mikolajczak1, Ahmed S I Aly, Ronald F Dumpit, Ashley M Vaughan, Stefan H I Kappe.   

Abstract

In this report, we describe a cloning procedure for gene replacement by double homologous recombination in Plasmodium yoelii, which requires only one digestion and ligation step. This significantly shortens the time required to complete the production of the targeting vector. Furthermore, for more efficient phenotypic evaluation of the gene knockout parasites, we have also introduced a fluorescent protein cassette into the targeting vector. This allows for a more rapid assessment of parasite growth in all of its developmental stages. In addition, the introduction of the fluorescent marker via the replacement strategy confers the stable integration of the marker.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18242728     DOI: 10.1016/j.molbiopara.2007.12.006

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  18 in total

1.  SSP3 is a novel Plasmodium yoelii sporozoite surface protein with a role in gliding motility.

Authors:  Anke Harupa; Brandon K Sack; Viswanathan Lakshmanan; Nadia Arang; Alyse N Douglass; Brian G Oliver; Andrew B Stuart; D Noah Sather; Scott E Lindner; Kevin Hybiske; Motomi Torii; Stefan H I Kappe
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Plasmodium Apicoplast Gln-tRNAGln Biosynthesis Utilizes a Unique GatAB Amidotransferase Essential for Erythrocytic Stage Parasites.

Authors:  Boniface M Mailu; Ling Li; Jen Arthur; Todd M Nelson; Gowthaman Ramasamy; Karin Fritz-Wolf; Katja Becker; Malcolm J Gardner
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

3.  Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host.

Authors:  Sebastian A Mikolajczak; Hilda Silva-Rivera; Xinxia Peng; Alice S Tarun; Nelly Camargo; Vanessa Jacobs-Lorena; Thomas M Daly; Lawrence W Bergman; Patricia de la Vega; Jack Williams; Ahmed S I Aly; Stefan H I Kappe
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

Review 4.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

5.  Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites.

Authors:  Alexis Kaushansky; Nastaran Rezakhani; Henning Mann; Stefan H I Kappe
Journal:  Mol Biochem Parasitol       Date:  2012-02-08       Impact factor: 1.759

Review 6.  Plasmodium immunomics.

Authors:  Denise L Doolan
Journal:  Int J Parasitol       Date:  2010-09-16       Impact factor: 3.981

7.  The primase domain of PfPrex is a proteolytically matured, essential enzyme of the apicoplast.

Authors:  Scott E Lindner; Manuel Llinás; James L Keck; Stefan H I Kappe
Journal:  Mol Biochem Parasitol       Date:  2011-08-11       Impact factor: 1.759

8.  Plasmodium yoelii inhibitor of cysteine proteases is exported to exomembrane structures and interacts with yoelipain-2 during asexual blood-stage development.

Authors:  Ying Pei; Jessica L Miller; Scott E Lindner; Ashley M Vaughan; Motomi Torii; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

9.  Perturbations of Plasmodium Puf2 expression and RNA-seq of Puf2-deficient sporozoites reveal a critical role in maintaining RNA homeostasis and parasite transmissibility.

Authors:  Scott E Lindner; Sebastian A Mikolajczak; Ashley M Vaughan; Wonjong Moon; Brad R Joyce; William J Sullivan; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2013-02-27       Impact factor: 3.715

Review 10.  Pre-erythrocytic malaria vaccines: identifying the targets.

Authors:  Patrick E Duffy; Tejram Sahu; Adovi Akue; Neta Milman; Charles Anderson
Journal:  Expert Rev Vaccines       Date:  2012-10       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.